News and features

Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

Test Tubes
Genetic testing could identify men at a 10-fold increased risk of testicular cancer

27/10/15

A new study of more than 25,000 men has uncovered four new genetic variants associated with increased risk of testicular cancer.
ICR Logo
Chemical probe to dissect role of potential cancer-causing proteins

26/10/15

Scientists have created a highly specific chemical probe to shed new light on the role two important proteins play in driving cancer cell proliferation.
Melanoma cells, Dr ChrisBakal, ICR, 2015
T-VEC becomes first viral immunotherapy recommended for approval in Europe

23/10/15

A viral immunotherapy for cancer has become the first to be given the green light by European regulators.
ICR Logo
Study identifies new treatment target in BRCA2-mutant prostate cancer

22/10/15

Genetic abnormalities associated with poor prognosis in prostate cancer are particularly common in men with germline mutations in the BRCA2 gene.
Breast Cancer scan
Test could predict whether breast cancer will spread to the brain

21/10/15

Women with particularly aggressive forms of breast cancer could be identified by a test that predicts whether the disease is likely to spread to the brain.
ICR Logo
Another successful year for the ICR team at the Royal Parks Half Marathon

20/10/15

All 24 of our runners in the Royal Parks Half Marathon completed the 13.1 mile course and together are set to raise £25,000 for our research.
Professor Janet Shipley in the lab
ICR scientists set to conquer Mount Snowdon for research into rare teenage cancer

16/10/15

A team of scientists from The Institute of Cancer Research, London, are embarking on a series of fundraising challenges in support of two parent-led charities committed to funding the ICR’s research into teenage cancer.
Test Tubes
New test to predict relapse of testicular cancer

16/10/15

Assessing just three features of a common kind of testicular cancer can identify those at most at risk of relapse.
Breast epithelial cells under ER stress (Chris Bakal, 2014)
Blood test could match cancer patients to best treatments

15/10/15

Scientists have developed a blood test that could match cancer patients with the most suitable therapy and track the tumour’s progress to see if the treatment is working.
Doctors and child patient
New test could help personalise treatment for common childhood cancer

15/10/15

A new test that examines the activity of only five genes can identify which patients are likely to suffer more aggressive forms of the childhood cancer rhabdomyosarcoma.
Tablets of abiraterone acetate, a drug discovered and developed at the ICR
Abiraterone made available earlier for men in Scotland

13/10/15

Abiraterone has been made available on the NHS in Scotland for men with advanced prostate cancer before treatment with chemotherapy.
dna-sequence
Scientists uncover four different types of bowel cancer

12/10/15

Bowel cancer can be divided up into four distinct diseases, each with its own set of biological characteristics, a major new study reports.

Make a donation today

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Our research centres & divisions

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and strategic initiatives.